Sanofi (SNYNF) Operating Income (QoQ) (2009 - 2026)

Sanofi (SNYNF) Operating Income (QoQ) (2009 - 2026) Analysis & Trends

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Eli Lilly	1,066.16 Bn	1,060.88 Bn	16.22 Bn
2	Johnson & Johnson	611.69 Bn	589.64 Bn	15.96 Bn
3	AbbVie	444.34 Bn	434.99 Bn	10.78 Bn
4	Astrazeneca	284.94 Bn	277.05 Bn	12.61 Bn
5	Merck	224.23 Bn	218.58 Bn	12.09 Bn
6	Amgen	195.12 Bn	183.08 Bn	5.87 Bn
7	Gilead Sciences	156.45 Bn	148.73 Bn	5.52 Bn
8	Pfizer	136.01 Bn	123.24 Bn	-1.21 Bn
9	Novartis Ag	113.45 Bn	113.67 Bn	-
10	Sanofi	-	-	9.49 Bn

Historic Data

Download Data

Date	Value
Mar 31, 2026	7.45%
Dec 31, 2025	-69.97%
Sep 30, 2025	221.50%
Jun 30, 2025	11.33%
Mar 31, 2025	-50.00%
Dec 31, 2024	68.27%
Sep 30, 2024	19.97%
Jun 30, 2024	1.95%
Mar 31, 2024	-76.87%
Dec 31, 2023	260.18%
Sep 30, 2023	11.97%
Jun 30, 2023	-0.78%
Mar 31, 2023	-36.51%
Dec 31, 2022	45.42%
Sep 30, 2022	7.66%
Jun 30, 2022	4.61%
Mar 31, 2022	-51.12%
Dec 31, 2021	90.32%
Sep 30, 2021	11.18%
Jun 30, 2021	2.77%